Matthew Pulisic
Vermogen: 850 663 $ op 31-05-2026
Vermogen: 850 663 $ op 31-05-2026
Matthew Pulisic is currently Chief Financial & Accounting Officer at Genelux Corp.
since 2025.
Formerly, Mr. Pulisic was Vice President-Finance at Arrowhead Pharmaceuticals, Inc. from 2020 to 2025.
Education includes an undergraduate degree from the University of California, Santa Cruz and an MBA from California Lutheran University School of Business Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENELUX CORP. 0,62% | 16-06-2026 | 278.906 ( 0,62% ) | 850 663 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GENELUX CORPORATION | Financieel Directeur/CFO | 30-01-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31-01-2025 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Lutheran University School of Business Management
California Lutheran University School of Business Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau